Biology Reference
In-Depth Information
[137] Miura Y, Thoburn CJ, Bright EC, Phelps ML, Shin T, Matsui EC, et al. Associa-
tion of Foxp3 regulatory gene expression with graft-versus-host disease. Blood
2004;104:2187-93.
[138] Bour-Jordan H, Bluestone JA. Regulating the regulators: costimulatory signals control
the homeostasis and function of regulatory T cells. Immunol Rev 2009;229:41-66.
[139] Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, Sharpe A, et al. B7/CD28
costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory
T cells that control autoimmune diabetes. Immunity 2000;12:431-40.
[140] Johnson BD, Konkol MC, Truitt RL. CD25+ immunoregulatory T-cells of donor origin
suppress alloreactivity after BMT. Biol Blood Marrow Transplant 2002;8:525-35.
[141] Tang Q, Henriksen KJ, Boden EK, Tooley AJ, Ye J, Subudhi SK, et al. Cutting edge:
CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J Immunol
2003;171:3348-52.
[142] Burr JS, Savage ND, Messah GE, Kimzey SL, Shaw AS, Arch RH, et al. Cutting edge:
distinct motifs within CD28 regulate T cell proliferation and induction of Bcl-XL. J Im-
munol 2001;166:5331-5.
[143] Tai X, Cowan M, Feigenbaum L, Singer A. CD28 costimulation of developing thymo-
cytes induces Foxp3 expression and regulatory T cell differentiation independently of
interleukin 2. Nat Immunol 2005;6:152-62.
[144] Fisson S, Darrasse-Jeze G, Litvinova E, Septier F, Klatzmann D, Liblau R, et al. Continu-
ous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J Exp
Med 2003;198:737-46.
[145] Walker LS, Chodos A, Eggena M, Dooms H, Abbas AK. Antigen-dependent proliferation
of CD4+ CD25+ regulatory T cells in vivo. J Exp Med 2003;198:249-58.
[146] Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, Ye J, et al. In vitro-expanded antigen-
specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004;199:1455-65.
[147] D'Cruz LM, Klein L. Development and function of agonist-induced CD25+Foxp3+
regulatory T cells in the absence of interleukin 2 signaling. Nat Immunol
2005;6:1152-9.
[148] Setoguchi R, Hori S, Takahashi T, Sakaguchi S. Homeostatic maintenance of natural
Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of auto-
immune disease by IL-2 neutralization. J Exp Med 2005;201:723-35.
[149] Semple K, Nguyen A, Yu Y, Wang H, Anasetti C, Yu XZ. Strong CD28 costimulation sup-
presses induction of regulatory T cells from naive precursors through Lck signaling.
Blood 2011;117:3096-103.
[150] Friedline RH, Brown DS, Nguyen H, Kornfeld H, Lee J, Zhang Y, et al. CD4+ regula-
tory T cells require CTLA-4 for the maintenance of systemic tolerance. J Exp Med
2009;206:421-34.
[151] Ise W, Kohyama M, Nutsch KM, Lee HM, Suri A, Unanue ER, et al. CTLA-4 suppresses
the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic
mechanisms. Nat Immunol 2010;11:129-35.
[152] Jain N, Nguyen H, Chambers C, Kang J. Dual function of CTLA-4 in regulatory T cells
and conventional T cells to prevent multiorgan autoimmunity. Proc Natl Acad Sci USA
2010;107:1524-8.
[153] Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z, et al. CTLA-4
control over Foxp3+ regulatory T cell function. Science 2008;322:271-5.
[154] Munn DH, Sharma MD, Lee JR, Jhaver KG, Johnson TS, Keskin DB, et al. Potential
regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.
Science 2002;297:1867-70.
[155] Grohmann U, Orabona C, Fallarino F, Vacca C, Calcinaro F, Falorni A, et al. CTLA-4-Ig
regulates tryptophan catabolism in vivo. Nat Immunol 2002;3:1097-101.
[156] Onishi Y, Fehervari Z, Yamaguchi T, Sakaguchi S. Foxp3+ natural regulatory T cells pref-
erentially form aggregates on dendritic cells in vitro and actively inhibit their matura-
tion. Proc Natl Acad Sci USA 2008;105:10113-8.
[157] Miyamoto K, Kingsley CI, Zhang X, Jabs C, Izikson L, Sobel RA, et al. The ICOS mol-
ecule plays a crucial role in the development of mucosal tolerance. J Immunol
2005;175:7341-7.
[158] Herman AE, Freeman GJ, Mathis D, Benoist C. CD4+CD25+ T regulatory cells depen-
dent on ICOS promote regulation of effector cells in the prediabetic lesion. J Exp Med
2004;199:1479-89.
[159] Kornete M, Sgouroudis E, Piccirillo CA. ICOS-dependent homeostasis and func-
tion of Foxp3+ regulatory T cells in islets of nonobese diabetic mice. J Immunol
2012;188:1064-74.
[160] Akbari O, Freeman GJ, Meyer EH, Greenfield EA, Chang TT, Sharpe AH, et al. Antigen-
specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit
allergen-induced airway hyperreactivity. Nat Med 2002;8:1024-32.
221
Search WWH ::
Custom Search